Halozyme Therapeutics | Операционный Доход


Operating Profit Изменить
DBV Technologies DBVT:US -23823000 7.05M
Acadia Pharmaceuticals ACAD:US $ -33.65M 79.36M
Agios Pharmaceuticals AGIO:US $ -94.94M 3.5M
Alnylam Pharmaceuticals ALNY:US $ -191.69M 44.95M
Amarin AMRN:US $ -62.83M 34.52M
Amgen AMGN:US $ 2176M 324M
Baxter International BAX:US $ 351M 188M
Cara Therapeutics CARA:US $ -4472000 23.44M
Cytokinetics CYTK:US $ -10.87M 69.68M
Eli Lilly And LLY:US $ 1210.1M 1194.2M
Esperion Therapeutics ESPR:US $ -52376000 9.39M
Halozyme Therapeutics HALO:US $ 34.06M 41.61M
Immunogen IMGN:US $ -61.05M 38.2M
Intercept Pharmaceuticals ICPT:US $ -13.36M 3.09M
Intra Cellular Therapies ITCI:US $ -87.92M 15.26M
Intrexon XON:US $ -24.16M 6.27M
IONIS PHARMACEUT IONS:US $ -85.51M 28.01M
JAZZ PHA JAZZ:US $ 85.55M 2M
Mannkind MNKD:US $ -20.45M 0.8M
Minerva Neurosciences NERV:US $ -6.96M 1.02M
Nektar Therapeutics NKTR:US $ -152.84M 36.28M
Peregrine Pharmaceuticals PPHM:US $ 1.07M 2.2M
Pfizer PFE:US $ 12102M 2229M
Rigel Pharmaceuticals RIGL:US $ -12.96M 13.3M
United Therapeutics UTHR:US $ 201.8M 84.5M
Vanda Pharmaceuticals VNDA:US $ 3.46M 11.13M



Halozyme Therapeutics Операционный Доход - Текущие значения, предыдущие значения, прогнозы, графики и экономический календарь - Aug 2022.